Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 8-K, Date: 2013-05-20
Original SEC Filing: Click here

---

Webplus: TPI/20130520/8-K/2_EX-99.1/000.htm SEC Original: f8k051513ex99i_tianyin.htm
TPI Reports Third Quarter Fiscal Year 2013 Financial Results CHENGDU, China, May 14, 2013 Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for third quarter of the fiscal year 2013. Third Quarter Fiscal Year 2013 Ended March 31,

---

---

Webplus: TPI/20130520/8-K/3_EX-99.2/000.htm SEC Original: f8k051513ex99ii_tianyin.htm
Tianyin Pharmaceutical Co., Inc. (TPI) F3Q13 Earnings Call May 15, 2013 9:00 AM EST Operator I would now like to turn the conference over to Dr. James Tong, Chief Financial Officer. Please go ahead, sir. Dr. James Tong – Chief Financial Officer Third quarter of fiscal year 2013 financial highlights – revenue $15.5 million compared with $14.4 million in the

---

---

Webplus: TPI/20130520/8-K/1/000.htm SEC Original: f8k051513_tianyin.htm
CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT May 15, 2013 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o

---

Company Information:

Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 8-K, Date: 2013-05-20CIK: 0001362718, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
23RD FLOOR, UNIONSUN YANGKUO PLAZA
CHENGDU, P.R. 610041